Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.
about
Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycyclineChronic Lyme diseaseChronic Lyme disease: a reviewTreatment for the neurological complications of Lyme diseaseLyme disease--current state of knowledgeDecreased up-regulation of the interleukin-12Rbeta2-chain and interferon-gamma secretion and increased number of forkhead box P3-expressing cells in patients with a history of chronic Lyme borreliosis compared with asymptomatic Borrelia-exposed indiA systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme diseaseBullying Borrelia: when the culture of science is under attack.Spirochete antigens persist near cartilage after murine Lyme borreliosis therapyTreatment trials for post-Lyme disease symptoms revisited.Proof that chronic lyme disease exists.Correlates of perceived health-related quality of life in post-treatment Lyme encephalopathy.Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.Implications of gender in chronic Lyme diseaseEffectiveness of Stevia Rebaudiana Whole Leaf Extract Against the Various Morphological Forms of Borrelia Burgdorferi in Vitro.Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndromeChronic Lyme disease: the controversies and the science.Antiscience and ethical concerns associated with advocacy of Lyme disease.Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.Doxycycline-mediated effects on persistent symptoms and systemic cytokine responses post-neuroborreliosis: a randomized, prospective, cross-over study.Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosisLyme neuroborreliosis-epidemiology, diagnosis and management.Generalizability in two clinical trials of Lyme disease.Lyme disease: the next decade.Health care costs, utilization and patterns of care following Lyme disease.Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome.Sustained-release formulation of doxycycline hyclate for prophylaxis of tick bite infection in a murine model of Lyme borreliosisBenefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease.Chronic Lyme disease: misconceptions and challenges for patient managementIdentification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library.Unorthodox alternative therapies marketed to treat Lyme disease.A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug LibraryLong-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndromeDetection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viabilityReview of evidence for immune evasion and persistent infection in Lyme disease.Long-term neuropsychological deficits after central nervous system infections despite adequate therapy.Management of Lyme disease.Management of neuroborreliosis in European adult patients.Controversies in Persistent (Chronic) Lyme Disease.
P2860
Q21131821-516B77DD-3FB3-447B-84F0-70120B8CD739Q22252195-507C51D0-FCF6-4B0A-B1A1-1E02A6CCB0B5Q22252200-8D7B60EB-B197-4CB0-90EA-AF52A1250CAAQ24243765-B75C8228-6271-44DC-8A67-363293885C5DQ24647011-143F71F1-3FC5-4836-8FE8-2E82CB9F3F95Q24683324-4781C68D-A93A-4F57-A651-8D1E74ADFB14Q26860866-E184E25B-9360-447C-8681-548F24784FBEQ30425726-3F461468-FA47-4480-8BE1-3E3E141032ACQ30519448-AE117C31-FAB5-4EC3-B300-813AF43AC0BDQ33822701-8CBC25BC-41DC-4F13-8651-769E5CEEB7FBQ33876091-4CDAA70D-3FF2-4C5E-B0BF-0A57BCEA753AQ33898972-5F1E639B-6497-4F7F-9543-EA557FD8AC4CQ33965485-10F504DD-927E-4987-9690-B3AEFDC2AF05Q34035280-01CFD9B9-18DA-46C2-8F1C-137AEE1C5CEBQ34045749-9B09BB0C-266B-4C40-AC18-78A110B99CADQ34202515-4ECA728A-E743-4AAA-BCF6-91CFC3D3BF17Q34205531-14C44C8F-4158-4105-BCC3-C44E022E38D9Q34210918-106EAA50-07C6-4212-B871-A1A2A18B8270Q34336214-01183FD5-9D31-44AF-97FD-0A22553D955CQ34372745-B46DBBE1-4252-49FB-B537-80C0CE26385FQ34374899-34F8DA0A-D7A1-43B9-87F5-FBB48CD60CE6Q34487119-629253BD-F9A6-466A-B838-F52D91D89A4DQ34574254-38B7B1B8-73DC-462B-918B-73D6B75BC775Q35026635-2ECECECC-53BC-4A70-BD80-30CB14B8A635Q35049415-FD47A84B-628E-46E3-A2FC-B60C2D173363Q35066111-2A311911-9C14-482B-86E1-273B6FDCF83FQ35125790-B29DD9F6-AFC7-45ED-A91B-6A8D0C5B9F1AQ35225117-79E0970B-84CE-416D-8E72-85E2E517677FQ35633278-024543C5-CE70-468A-AD09-F499F87B5E32Q35650795-7CE62A4C-29F3-4121-8F15-0C558A1157E4Q35813321-DB96843A-BBBA-4410-A6DF-53B085378F43Q36034530-8FB48027-899F-4089-AE4E-48C6EBF3EBBFQ36311452-29520FF6-B8A6-4FDF-A027-0D745DF81C96Q36328746-77493C72-9B7E-4087-B49E-369FC0F06956Q36667562-FEA25B32-4CD1-487F-A0B5-2D0DB6F76239Q36797128-0494D3C5-0C54-4047-A929-6C4198DF80D2Q36822103-A62FB0AA-3E74-4052-BA2E-F6F1F92D08C8Q37124900-3F525D3D-50D4-4AC1-ADD1-20EA6DFDA2ACQ37148487-D2B8E859-857C-4EF0-AE9C-6BEC275AF269Q37403994-56FBEAB7-3FB0-4A58-A0F0-21E1A2326FA4
P2860
Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Study and treatment of post Ly ...... double masked clinical trial.
@ast
Study and treatment of post Ly ...... double masked clinical trial.
@en
Study and treatment of post Lyme disease
@nl
type
label
Study and treatment of post Ly ...... double masked clinical trial.
@ast
Study and treatment of post Ly ...... double masked clinical trial.
@en
Study and treatment of post Lyme disease
@nl
prefLabel
Study and treatment of post Ly ...... double masked clinical trial.
@ast
Study and treatment of post Ly ...... double masked clinical trial.
@en
Study and treatment of post Lyme disease
@nl
P2093
P1433
P1476
Study and treatment of post Ly ...... double masked clinical trial.
@en
P2093
B Chandler
P Melville
R Dattwyler
P304
P356
10.1212/01.WNL.0000071227.23769.9E
P407
P577
2003-06-01T00:00:00Z